EFG Asset Management North America Corp. Purchases 706 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

EFG Asset Management North America Corp. raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 9.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,577 shares of the biotechnology company’s stock after acquiring an additional 706 shares during the quarter. EFG Asset Management North America Corp.’s holdings in Axon Enterprise were worth $5,095,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in AXON. Prestige Wealth Management Group LLC grew its holdings in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at about $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise during the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise in the 4th quarter valued at about $45,000. Finally, Stonebridge Financial Group LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $53,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

AXON stock opened at $572.52 on Tuesday. The firm has a market cap of $43.87 billion, a PE ratio of 147.94, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The stock has a 50-day moving average price of $591.98 and a 200-day moving average price of $545.11. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Wall Street Analysts Forecast Growth

AXON has been the subject of several recent analyst reports. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Barclays restated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $604.67.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.